Fucoidan Reduces Heart Damage in Mice with High Blood Pressure
Author Information
Author(s): Hao Wen-Rui, Cheng Chun-Han, Chen Huan-Yuan, Cheng Tzu-Hurng, Liu Ju-Chi, Chen Jin-Jer, Zhao Yang, Zhang Jifeng, Xue Chao
Primary Institution: China Medical University
Hypothesis
Can fucoidan inhibit Galectin-3 activity and reduce heart damage in mice with pressure overload?
Conclusion
Fucoidan effectively reduced heart damage and inflammation in mice with pressure overload, suggesting it may help prevent heart disease.
Supporting Evidence
- Fucoidan treatment reduced heart and left ventricular weights in mice with pressure overload.
- Echocardiographic evaluations showed improved cardiac function in fucoidan-treated mice.
- Histological analysis revealed reduced collagen deposition and inflammation in the hearts of fucoidan-treated mice.
- Fucoidan significantly lowered serum levels of Galectin-3, a protein linked to heart damage.
- Western blot analysis showed decreased expression of inflammatory and fibrotic markers in fucoidan-treated groups.
Takeaway
Fucoidan is like a superhero for the heart, helping to fix damage and keep it healthy when there's too much pressure.
Methodology
Mice underwent surgery to create pressure overload and were treated with fucoidan to assess its effects on heart function and structure.
Limitations
The study lacked a sham group with fucoidan to assess its baseline effects and did not measure pressure gradients during the experiment.
Participant Demographics
Male C57BL/6J mice, aged 8–10 weeks, weighing 23.5 to 27.5 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website